about
Minocycline for acne vulgaris: efficacy and safetyMinocycline for acne vulgaris: efficacy and safetyAcne vulgarisComprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocyclineCritical data-based re-evaluation of minocycline as a putative specific microglia inhibitor.Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measuresDo selected drugs increase the risk of lupus? A matched case-control study.Pharmacological regulators of autophagy and their link with modulators of lupus diseasePotential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease.Minocycline suppresses activation of nuclear factor of activated T cells 1 (NFAT1) in human CD4+ T cellsDrug-induced glomerular disease: immune-mediated injury.Minimising the potential for metabolic activation in drug discovery.Systemic antibiotic therapy of acne vulgaris.Drug-induced lupus erythematosus: incidence, management and prevention.Vasculitic neuropathy following exposure to minocycline.Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus.Lupus syndrome with neutropenia following minocycline therapy - a case report.Is minocycline therapy in acne associated with antineutrophil cytoplasmic antibody positivity? A cross-sectional study.Sensory Processing Phenotypes in Fragile X Syndrome
P2860
Q24201716-1C0D40D5-6C6E-4223-9DDC-FA8AF277B8EDQ24250316-F33EAA4A-A454-439C-A6A3-2D04839E4522Q24634131-B7864F22-F15C-4F60-B55A-B73CDDB700ECQ28748449-99038DE3-A120-4E49-BAB5-8DD739EF65ECQ31104505-D93FD739-3B96-4EDC-AC71-32203F74BC4CQ33650170-9E03FBD4-74C0-41C7-84F6-807C5D504E3EQ34180488-DA974291-C364-40DA-9297-351FA9FA2665Q34402759-13281786-F7F1-4357-948F-6E6C0C47C07DQ34622394-A3C56D77-12C0-41CA-B96D-24B663449872Q34719602-4861B3A8-7E96-4CBB-AB65-E001255AEFA1Q35816996-D8BA307D-66EE-4972-9838-80160BD75D8BQ36572637-947A9B15-9DFF-4E03-BF7F-88AB1DCC575BQ36607558-2BFCA0AC-515F-4033-BC1D-9BA7C6E17855Q37868002-0FDF3ECE-1C9C-4AA2-9777-54CE6FDA17BFQ40129735-9220A01E-3B96-4C57-ABA5-E00B08448733Q43789533-5B0FC483-1E88-4380-A581-5BBD6EBA1220Q46265408-F84984A2-73BB-4A05-819D-2D2299B15C30Q52854066-7134D53B-D667-4915-BEAF-3F03ACC83F60Q58718525-75C259B6-04C6-4167-B3CE-99A27BCFBB95
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Minocycline-induced lupus. A systematic review.
@ast
Minocycline-induced lupus. A systematic review.
@en
type
label
Minocycline-induced lupus. A systematic review.
@ast
Minocycline-induced lupus. A systematic review.
@en
prefLabel
Minocycline-induced lupus. A systematic review.
@ast
Minocycline-induced lupus. A systematic review.
@en
P2093
P356
P1433
P1476
Minocycline-induced lupus. A systematic review.
@en
P2093
A J Bircher
R G Schlienger
P304
P356
10.1159/000018387
P577
2000-01-01T00:00:00Z